A detailed history of Sargent Bickham Lagudis LLC transactions in Amyris, Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 23 shares of AMRS stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 23 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

SELL
$1.7 - $4.05 $6 - $16
-4 Reduced 14.81%
23 $0
Q3 2021

Nov 05, 2021

BUY
$12.13 - $16.99 $315 - $441
26 Added 2600.0%
27 $0
Q2 2020

Sep 07, 2021

BUY
$2.17 - $5.35 $2 - $5
1 New
1 $0

Others Institutions Holding AMRS

About AMYRIS, INC.


  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.